Find API Reference Price of Moricizine on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 29560-58-5, Moracizine hydrochloride, Ethmozine, Ethmosine, Moricizine hcl, Moricizine (hydrochloride)
Molecular Formula
C22H26ClN3O4S
Molecular Weight
464.0  g/mol
InChI Key
GAQAKFHSULJNAK-UHFFFAOYSA-N
FDA UNII
71OK3Z1ESP

Moricizine
An antiarrhythmia agent used primarily for ventricular rhythm disturbances.
1 2D Structure

Moricizine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate;hydrochloride
2.1.2 InChI
InChI=1S/C22H25N3O4S.ClH/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24;/h3-8,15H,2,9-14H2,1H3,(H,23,27);1H
2.1.3 InChI Key
GAQAKFHSULJNAK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4.Cl
2.2 Other Identifiers
2.2.1 UNII
71OK3Z1ESP
2.3 Synonyms
2.3.1 MeSH Synonyms

1. En 313

2. En-313

3. En313

4. Ethmozin

5. Ethmozine

6. Etmozin

7. Hydrochloride, Moricizine

8. Moracizin

9. Moracizine

10. Moricizine

2.3.2 Depositor-Supplied Synonyms

1. 29560-58-5

2. Moracizine Hydrochloride

3. Ethmozine

4. Ethmosine

5. Moricizine Hcl

6. Moricizine (hydrochloride)

7. Ethmozin

8. Etmozin

9. 71ok3z1esp

10. Mls000830274

11. Moricizine Hydrochloride [usp]

12. En 313; Ethmosine; Ethmozin

13. En 313

14. Ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate;hydrochloride

15. Moracizine Hcl

16. Smr000036736

17. Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate, Hydrochloride

18. Dsstox_cid_27766

19. Dsstox_rid_82543

20. Dsstox_gsid_47786

21. Carbamic Acid, (10-(3-(4-morpholinyl)-l-oxopropyl)-10h-phenothiazin-2yl)-, Ethyl Ester, Hydrochloride

22. Moricizine Hydrochloride (usp)

23. Ethyl 10-(beta-n-morpholinylpropionyl)phenothiazine-2-carbamate Hydrochloride

24. Chebi:60937

25. Cas-29560-58-5

26. Ncgc00016809-01

27. Ncgc00016809-07

28. Unii-71ok3z1esp

29. Ethmozine (tn)

30. Opera_id_267

31. Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate Hydrochloride

32. Cambridge Id 5229972

33. Ethyl Ether Of 10-(beta-morpholylpropionyl)phenthiazinecarbamino Acid Hydrochloride

34. Moracizinehydrochloride

35. Schembl41358

36. (10-(3-(4-morpholinyl)-1-oxopropyl)-10h-phenothiazin-2-yl)carbamic Acid, Ethyl Ester, Monohydrochloride

37. Mls000080120

38. Regid_for_cid_34632

39. Chembl1200334

40. Dtxsid1047786

41. Hy-b0615a

42. Hms1571c04

43. Ethyl 10-(3-morpholinopropanoyl)-

44. Tox21_110622

45. Moricizine Hydrochloride [mi]

46. Akos030506898

47. Tox21_110622_1

48. Ccg-221051

49. Moracizine Hydrochloride [mart.]

50. Moricizine Hydrochloride [vandf]

51. Phenothiazine-2-carbamic Acid, 10-(3-morpholinopropionyl)-, Ethyl Ester, Hydrochloride

52. Moracizine Hydrochloride [who-dd]

53. Moricizine Hydrochloride [usp-rs]

54. Ncgc00180924-01

55. Carbamic Acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10h-phenothiazin-2-yl)-, Ethyl Ester, Monohydrochloride

56. Db-047605

57. Cs-0013699

58. E-313

59. E-350

60. Ft-0630550

61. Moricizine Hydrochloride [orange Book]

62. D02087

63. Moricizine Hydrochloride [usp Impurity]

64. Sr-01000614327

65. Sr-01000614327-4

66. Q27130132

67. Ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate;hydron;chloride

68. Carbamic Acid, N-(10-(3-(4-morpholinyl)-1-oxopropyl)-10h-phenothiazin-2-yl)-, Ethyl Ester, Hydrochloride (1:1)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 464.0 g/mol
Molecular Formula C22H26ClN3O4S
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass463.1332552 g/mol
Monoisotopic Mass463.1332552 g/mol
Topological Polar Surface Area96.4 Ų
Heavy Atom Count31
Formal Charge0
Complexity601
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)


Voltage-Gated Sodium Channel Blockers

A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty